GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a significant focus in healthcare studies, largely due to its remarkable impact on managing diseases such as adult-onset diabetes and excess body fat. Recent research have demonstrated that beyond glucose control, GLP-1 agonists offer promise for heart health and perh… Read More